DJ Vertex Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Vertex Pharmaceuticals Inc. $(VRTX)$ rose 1.17% to $522.38 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.02% to 7,704.13 and Dow Jones Industrial Average falling 0.31% to 51,349.98.
This was the stock's fourth consecutive day of gains.
Vertex Pharmaceuticals Inc. closed 6.76% below its 52-week high of $560.25, which the company achieved on September 3rd.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as AbbVie Inc. $(ABBV)$ rose 0.02% to $265.12, Krystal Biotech Inc. (KRYS) rose 0.94% to $344.96, and Arcturus Therapeutics Holdings Inc. $(ARCT)$ rose 6.17% to $14.12.
Trading volume (926,422) remained 261,088 below its 50-day average volume of 1.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 24, 2026.
Comments